Compounds > pravastatin

Page last updated: 2024-08-23

pravastatin and Cataract

pravastatin has been researched along with Cataract in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
MacDonald, JS	1
Notkola, IL; Rouhiainen, H; Rouhiainen, P; Salonen, JT	1
Rouhiainen, H; Rouhiainen, P; Salonen, JT	2
Behrens-Baumann, W; Thiery, J	1
Hockwin, O; Schmidt, J; Schmitt, C	2
Behrens-Baumann, W; Fieseler, HG; Seidel, D; Thiery, J	1

Trials

3 trial(s) available for pravastatin and Cataract

Article	Year
Comparison of the lens opacities classification system II and Lensmeter 701. American journal of ophthalmology, 1993, Nov-15, Volume: 116, Issue:5 Topics: Adult; Arteriosclerosis; Cataract; Cholesterol, LDL; Humans; Hypercholesterolemia; Lens Cortex, Crystalline; Lens Nucleus, Crystalline; Male; Middle Aged; Ophthalmology; Photography; Pravastatin; Sensitivity and Specificity	1993
Lens opacity increase in a longitudinal study: comparison of the lens opacities classification system II and lensmeter 701. Current eye research, 1996, Volume: 15, Issue:3 Topics: Adult; Anticholesteremic Agents; Arteriosclerosis; Cataract; Evaluation Studies as Topic; Humans; Hypercholesterolemia; Lens, Crystalline; Longitudinal Studies; Male; Middle Aged; Ophthalmology; Pravastatin; Prospective Studies; Sensitivity and Specificity	1996
Association between low plasma vitamin E concentration and progression of early cortical lens opacities. American journal of epidemiology, 1996, Sep-01, Volume: 144, Issue:5 Topics: Adult; Anticholesteremic Agents; Arteriosclerosis; Cataract; Chromatography, High Pressure Liquid; Disease Progression; Finland; Humans; Linear Models; Male; Middle Aged; Pravastatin; Risk Factors; Time Factors; Vitamin E	1996

Other Studies

5 other study(ies) available for pravastatin and Cataract

Article	Year
Perspective on cataractogenic potential of HMG-CoA reductase inhibitors. Experimental eye research, 1995, Volume: 60, Issue:1 Topics: Animals; Cataract; Dogs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Rabbits; Rats; Simvastatin	1995
Cataracts by lipid lowering drugs? Three different HMG-CoA reductase inhibitors studied in hypercholesterolemic rabbits. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1992, Volume: 192, Issue:1 Topics: Animals; Anticholesteremic Agents; Cataract; Cholesterol; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lovastatin; Pravastatin; Rabbits; Simvastatin	1992
[The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans]. Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1991, Volume: 88, Issue:6 Topics: Adult; Cataract; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lovastatin; Middle Aged; Pravastatin; Refraction, Ocular; Risk Factors; Simvastatin; Visual Acuity	1991
Pravastatin--ocular side effects after a two year follow-up? Lens and eye toxicity research, 1990, Volume: 7, Issue:3-4 Topics: Aged; Anticholesteremic Agents; Cataract; Cholesterol, LDL; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Lens, Crystalline; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides	1990
Ocular drug-safety study with the HMG-CoA reductase inhibitor pravastatin. Lens and eye toxicity research, 1990, Volume: 7, Issue:3-4 Topics: Anterior Eye Segment; Cataract; Densitometry; Drug Evaluation; Eyelids; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Image Processing, Computer-Assisted; Intraocular Pressure; Lens, Crystalline; Male; Naphthalenes; Photography; Pravastatin; Visual Acuity	1990